BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21719255)

  • 21. [Different responses of right and left ventricular diastolic function to pulmonary resection: echocardiographic study with leg elevation for preload augmentation].
    Takaki A; Sugi K; Sano T; Tanaka N; Matsuzaki M
    J Cardiol; 2000 Oct; 36(4):241-9. PubMed ID: 11079229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy.
    Nunes Mdo C; Rocha MO; Ribeiro AL; Colosimo EA; Rezende RA; Carmo GA; Barbosa MM
    Int J Cardiol; 2008 Jul; 127(3):372-9. PubMed ID: 17689706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of right ventricular apex pacing on the Tei index and brain natriuretic peptide in patients with a dual-chamber pacemaker.
    Ichiki H; Oketani N; Hamasaki S; Ishida S; Kataoka T; Ogawa M; Saihara K; Okui H; Fukudome T; Shinasato T; Kubozono T; Ninomiya Y; Matsushita T; Otsuji Y; Tei C
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):985-90. PubMed ID: 16981923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis.
    van Dockum WG; Kuijer JP; Götte MJ; Ten Cate FJ; Ten Berg JM; Beek AM; Twisk JW; Marcus JT; Visser CA; van Rossum AC
    Eur Heart J; 2006 Dec; 27(23):2833-9. PubMed ID: 17098761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnostic value of Tei index in detection of chronic heart failure in elderly patients].
    Bart BIa; Larina VN; Alekhin MN; Dergunova EN
    Ter Arkh; 2008; 80(4):15-21. PubMed ID: 18491574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T₁ mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex.
    Thompson RB; Chow K; Khan A; Chan A; Shanks M; Paterson I; Oudit GY
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):637-45. PubMed ID: 23922004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease.
    Talbot AS; Lewis NT; Nicholls KM
    Heart; 2015 Feb; 101(4):287-93. PubMed ID: 25381325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial lipid content in Fabry disease: a combined
    Petritsch B; Köstler H; Weng AM; Horn M; Gassenmaier T; Kunz AS; Weidemann F; Wanner C; Bley TA; Beer M
    BMC Cardiovasc Disord; 2016 Oct; 16(1):205. PubMed ID: 27793097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease.
    Krämer J; Niemann M; Störk S; Frantz S; Beer M; Ertl G; Wanner C; Weidemann F
    Am J Cardiol; 2014 Sep; 114(6):895-900. PubMed ID: 25073565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of Clinical Evolution in Prehypertrophic Fabry Disease.
    Camporeale A; Pieroni M; Pieruzzi F; Lusardi P; Pica S; Spada M; Mignani R; Burlina A; Bandera F; Guazzi M; Graziani F; Crea F; Greiser A; Boveri S; Ambrogi F; Lombardi M
    Circ Cardiovasc Imaging; 2019 Apr; 12(4):e008424. PubMed ID: 30943767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of Electrocardiographic Voltage to Determine Myocardial Fibrosis in Hypertrophic Cardiomyopathy.
    Konno T; Nagata Y; Teramoto R; Fujino N; Nomura A; Tada H; Sakata K; Furusho H; Takamura M; Nakamura H; Kawashiri MA; Yamagishi M; Hayashi K
    Am J Cardiol; 2016 Feb; 117(3):443-9. PubMed ID: 26705881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of asymmetric basal posterior wall thinning in patients with cardiac Fabry's disease.
    Kawano M; Takenaka T; Otsuji Y; Teraguchi H; Yoshifuku S; Yuasa T; Yu B; Miyata M; Hamasaki S; Minagoe S; Kanmura Y; Tei C
    Am J Cardiol; 2007 Jan; 99(2):261-3. PubMed ID: 17223430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated calculation of the Tei index from signal averaged left ventricular acoustic quantification wave forms.
    Spencer KT; Weinert L; Avi VM; Decara J; Lang RM
    J Am Soc Echocardiogr; 2002 Dec; 15(12):1485-9. PubMed ID: 12464916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The right ventricle in Fabry disease: natural history and impact of enzyme replacement therapy.
    Niemann M; Breunig F; Beer M; Herrmann S; Strotmann J; Hu K; Emmert A; Voelker W; Ertl G; Wanner C; Weidemann F
    Heart; 2010 Dec; 96(23):1915-9. PubMed ID: 20965976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echocardiographic assessment of fabry cardiomyopathy: early diagnosis and follow-up.
    Pieroni M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):1033-6. PubMed ID: 21867871
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy.
    Toro R; Perez-Isla L; Doxastaquis G; Barba MA; Gallego AR; Pintos G; Barbados FJ; Mangas A; Zamorano JL
    Int J Cardiol; 2009 Feb; 132(1):38-44. PubMed ID: 18691784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease.
    Augusto JB; Nordin S; Vijapurapu R; Baig S; Bulluck H; Castelletti S; Alfarih M; Knott K; Captur G; Kotecha T; Ramaswami U; Tchan M; Geberhiwot T; Fontana M; Steeds RP; Hughes D; Kozor R; Moon JC
    Circ Cardiovasc Imaging; 2020 Mar; 13(3):e010171. PubMed ID: 32114828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms.
    Weidemann F; Rummey C; Bijnens B; Störk S; Jasaityte R; Dhooge J; Baltabaeva A; Sutherland G; Schulz JB; Meier T;
    Circulation; 2012 Apr; 125(13):1626-34. PubMed ID: 22379112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Fabry Disease cardiac involvement according to longitudinal strain, cardiometabolic exercise test, and T1 mapping.
    Réant P; Testet E; Reynaud A; Bourque C; Michaud M; Rooryck C; Goizet C; Lacombe D; de-Précigout V; Peyrou J; Cochet H; Lafitte S
    Int J Cardiovasc Imaging; 2020 Jul; 36(7):1333-1342. PubMed ID: 32385539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Tissue Doppler Tei index for global left ventricular function in mice after myocardial infarction: comparison with Pulsed Doppler Tei index.
    Schaefer A; Meyer GP; Hilfiker-Kleiner D; Brand B; Drexler H; Klein G
    Eur J Echocardiogr; 2005 Oct; 6(5):367-75. PubMed ID: 16153558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.